Panel session 17:00

Watch the program
17:00 - 18:20

Grand Hall

A unifying role of the GxP in the conditions of the changing reality. Part 2

Questions and topics for discussion
• Special aspects of circulation of reference standards
• Crucial issues of good preclinical and good clinical practices
• From generics to innovations. Regulation and production of innovative and high-tech medicines
• The laboratory phase of pharmaceutical development as a fundamental pillar for quality and efficacy of a medicinal product
• Special aspects of batch release testing


The Session Partner: Akhrikhin

Moderator

Roman Drai

Roman Drai

R&D Director, Geropharm group of companies

Participants

Natalia Chadova

Miloš Luburić

GMP inspector, Institute for Medicines and Medical Devices (CInMED), Montenegro

Natalia Chadova

Valery Makarov

Director for Science, RMC "Home of Pharmacy"

Natalia Chadova

Natalia Malykh

Vice President for Business Development, the Pharmasyntez Group of Companies

Natalia Chadova

Mahmoud Fawaz Al-Qawasmeh

Head of the Drug Control and Inspection Department, Jordan Food and Drug Administration (JFDA), Jordan

Natalia Chadova

Pavel Burenkov

Deputy Head of the Inspection Authority of the FSI “State Institute of Drugs and Good Practices”, Russian Ministry of Industry and Trade

Natalia Chadova

Du Jing

GMP Inspector, Centre for Food and Drug Inspection (CFDI), China

Natalia Chadova

Dmitry Somov

Acting Director General of the Information Center for Expertise, Accounting and Analysis of Circulation of Medical Products, Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Natalia Chadova

Naala Grivapsh

Corporate Quality Director, Binnopharm Group of Companies

Natalia Chadova

Vladimir Gegechkori

Deputy Director General (Production and Strategic Development), National Centre for Reference Standards

Natalia Chadova

Deon Poovan

Senior Manager: Inspectorate and Regulatory Compliance, South African Health Products Regulatory Authority (SAHPRA), South Africa

Natalia Chadova

Leila Gargoubi

GMP Inspector at Direction of Inspection Department, Ministry of Health, Tunisia

Partners

Session content